Skip to main content

Hologic Value Stock - Dividend - Research Selection

Hologic

ISIN: US4364401012 , WKN: 879100

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company operates through five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health. It offers Aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assay technologies, instrumentation, Invader chemistry platform, ThinPrep system, and rapid fetal fibronectin test products. It also provides breast imaging and related products, and accessories comprising digital and film-based mammography systems; computer-aided detection for mammography; minimally invasive breast biopsy devices; breast biopsy site markers; and breast biopsy guidance systems. In addition, it offers Dimensions platform, a mammography gantry for 2D and tomosynthesis image acquisition and display; C-View and Intelligent 2D, a software product that provides 2D images; Selenia digital mammography platform; and SecurView Workstation. Further, it provides SculpSure, MonaLisa Touch, Vectus diode, and Cellulaze laser devices; PicoSure and Icon aesthetic systems; MedLite, RevLite, Cynergy, Elite, and SmartLipo products; and system components. Additionally, it offers NovaSure system to treat women suffering from abnormal uterine bleeding; MyoSure system for the hysteroscopic removal of fibroids; discovery and horizon X-ray bone densitometers that assess the bone density of fracture sites; and mini C-arm imaging systems to perform minimally invasive surgical procedures on a patient\'s extremities, such as the hand, wrist, knee, foot, and ankle. The company sells its products through direct sales and service forces, and a network of independent distributors and sales representatives. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Sector Update: Financial Stocks Mixed in Afternoon Trading

2025-10-21
Financial stocks were mixed in Tuesday afternoon trading with the NYSE Financial Index little change

Hologic (HOLX) Stock Is Up, What You Need To Know

2025-10-21
Shares of medical technology company Hologic (NASDAQ:HOLX) jumped 3.1% in the afternoon session after the company announced it agreed to be acquired by private equity firms Blackstone and TPG in a deal that takes the company private.

Sector Update: Health Care Stocks Advance Tuesday Afternoon

2025-10-21
Health care stocks rose Tuesday afternoon, with the NYSE Health Care Index up 0.2% and the Health Ca

Market Chatter: Blackstone, TPG Secure $12.25 Billion in Debt for Hologic Buyout

2025-10-21
Citigroup (C), Barclays (BCS), and Bank of America (BAC) are arranging $12.25 billion in debt to bac

Top Midday Stories: GM Shares Rise on Earnings Beat, Raised Guidance; Blackstone, TPG to Acquire Hologic

2025-10-21
The Dow Jones and the S&P 500 were up, while the Nasdaq Composite was flat in late-morning trading T

HOLX or IDXX: Which Is the Better Value Stock Right Now?

2025-10-21
HOLX vs. IDXX: Which Stock Is the Better Value Option?

Hologic, After Spiking On Rumors, Agrees To $18.3 Billion Take-Private Deal

2025-10-21
Hologic agreed Tuesday to be acquired by Blackstone and TPG in a deal that values the women's health tech company at up to $18.3 billion.

Halliburton's profit plummets, Hologic to go private in $18.3B deal

2025-10-21
Market Catalysts host Julie Hyman tracks several of the day's top trending stock tickers, including Galaxy Digital (GLXY.TO, GLXY) topping third quarter earnings estimates, Halliburton (HAL) seeing a massive drop in its net income, and Blackstone (BX) and TPG Inc. (TPG) agreeing to take Hologic (HOLX) private in a deal worth $18.3 billion. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.

Blackstone, TPG plan to take Hologic private in a deal worth more than $13 billion

2025-10-21
Private equity firms Blackstone and TPG will spend more than $13 billion to buy women’s health specialist Hologic. The companies said Tuesday they will pay up to $79 for each Hologic share in a deal that takes the company private. Shares of Hologic rose after markets opened Tuesday.

Blackstone, TPG to Buy Hologic for Up to $18.3 Billion

2025-10-21
Under the terms of the deal, Blackstone and TPG agreed to acquire all outstanding shares of the women’s-health company for $76 apiece in cash.